<i>Escherichia coli</i> Cyclopropane Fatty Acid Synthase:  Is a Bound Bicarbonate Ion the Active-Site Base?^† by Fabienne Courtois (2667262)

“…H266A, Y317F, E239A, and E239Q mutants were thus constructed and purified, and their catalytic efficiencies were 5.3, 0.7, 0.2, and <0.02%, respectively. …”

<i>Escherichia coli</i> Cyclopropane Fatty Acid Synthase:  Is a Bound Bicarbonate Ion the Active-Site Base?^† by Fabienne Courtois (2667262)

“…H266A, Y317F, E239A, and E239Q mutants were thus constructed and purified, and their catalytic efficiencies were 5.3, 0.7, 0.2, and <0.02%, respectively. …”

NG2 knockdown in GBM xenografts increased vascular reabsorption, decreased plasma volume and normalized tumour vasculature. by Jian Wang (5901)

Blocking C5L2 decreased MPO concentration in the supernatant of C5a-primed neutrophils. by Jian Hao (160736)

Expression of human PON1 decreases superoxide levels in the gut of <i>D. melanogaster</i>. by Alejandro A. Pezzulo (138238)

P63 and CD44 expression were decreased in triple mutants. by Kyung-Suk Choi (162073)

“…Np63 was expressed in the AER and epithelial cells of E10.5 and E11.5 control (A and C) and triple mutant hindlimbs (B and D). …”

Decreased Aβ42 halo overlaps with the decreased incidence of DNs in FO treated mice. by Milena Jović (6707702)

“…(E-H) In the FO-treated 5xFAD animals the decreased surface of the Aβ halo overlaps with the decreased incidence of swollen, dystrophic neurites.…”

Evolutionary time course of the average phenotypic variations <i>V</i>_<i>ip</i> and <i>V</i>_<i>g</i>. by Naoto Nishiura (11668953)

Subjects:

Silencing AXL in human colon cancer cells does not decrease proliferation. by Diana J. Uribe (2201695)

<i>Dicer</i> mutant animals show decreased eye size. by Rita Pinter (251068)

E2+P4 treatment protects mice against thromboembolism. by Marie-Cécile Valéra (4014953)

Subjects:

B-Raf^V600E plays a causal role in the induction of miR-10b. by Ila Datar (433874)

Decreases in oxygen induced Antxr1 transcription and expression at the cell surface. by N. J. Andersen (846668)

Bioavailable copper levels can be decreased in vivo by copper chelating agents. by Andrew Crowe (450839)

Bcl-x_L decreases ionomycin-induced MIMP. by Daniel Tornero (218854)

Decreased proliferation in the primitive streak occurs coincident with Oct4 depletion. by Brian DeVeale (174713)

The estrogen receptor-α agonist PPT decreases cardiac myofilament activation. by Justyna Kulpa (313372)

“…<p>Myocardium was treated with the estrogen receptor-α agonist PPT (100 nM) for 1 (A) (N = 9), 2.5 (B) (N = 9), or 5 min (C) (N = 22). …”

PAP decreases expression of HIV-1 proteins without toxicity to cells. by Sheila Mansouri (324272)

Gal 3/LPS interaction decreases mice resistance to the lethality of LPS. by Marise Lopes Fermino (341245)

Rash presentation of marmosets intravenously exposed to decreasing doses of monkeypox virus. by Eric M. Mucker (146111)

“…<p>Notice the rash becomes more focal in nature as the dose is decreased: 2.4 x 10⁷ PFU, A, 9.5 x 10⁵ PFU, B, 7.8 x 10⁴ PFU, C, 5.0 x 10³ PFU, D, 510 PFU, E, and 48 PFU.…”